This research report focuses on the Computational Drug Discovery Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Overview
- 1.2 Market Analysis by Type
- 1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
- 1.2.2 Structure-based Drug Design (SBDD)
- 1.2.3 Ligand-based Drug Design (LBDD)
- 1.2.4 Sequence-based Approaches
- 1.3 Market by Application
- 1.3.1 Global Computational Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
- 1.3.2 Oncological Disorders
- 1.3.3 Neurological Disorders
- 1.3.4 Immunological Disorders
- 1.3.5 Infectious Diseases
- 1.4 Assumptions and Limitations
2 Global Growth Trends
- 2.1 Global Computational Drug Discovery Market Perspective (2018-2029)
- 2.2 Global Computational Drug Discovery Growth Trends by Region
- 2.2.1 Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
- 2.2.2 Computational Drug Discovery Historic Market Size by Region (2018-2023)
- 2.2.3 Computational Drug Discovery Forecasted Market Size by Region (2024-2029)
- 2.3 Computational Drug Discovery Market Dynamics
- 2.3.1 Computational Drug Discovery Industry Trends
- 2.3.2 Computational Drug Discovery Market Drivers
- 2.3.3 Computational Drug Discovery Market Challenges
- 2.3.4 Computational Drug Discovery Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Computational Drug Discovery by Players
- 3.1.1 Global Computational Drug Discovery Revenue by Players (2018-2023)
- 3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2018-2023)
- 3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Computational Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
- 3.4 Global Computational Drug Discovery Market Concentration Ratio
- 3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2022
- 3.5 Global Key Players of Computational Drug Discovery Head office and Area Served
- 3.6 Global Key Players of Computational Drug Discovery, Product and Application
- 3.7 Global Key Players of Computational Drug Discovery, Date of Enter into This Industry
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Drug Discovery Breakdown Data by Type
- 4.1 Global Computational Drug Discovery Historic Market Size by Type (2018-2023)
- 4.2 Global Computational Drug Discovery Forecasted Market Size by Type (2024-2029)
5 Computational Drug Discovery Breakdown Data by Application
- 5.1 Global Computational Drug Discovery Historic Market Size by Application (2018-2023)
- 5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2024-2029)
6 North America
- 6.1 North America Computational Drug Discovery Market Size (2018-2029)
- 6.2 North America Computational Drug Discovery Market Size by Type
- 6.2.1 North America Computational Drug Discovery Market Size by Type (2018-2023)
- 6.2.2 North America Computational Drug Discovery Market Size by Type (2024-2029)
- 6.2.3 North America Computational Drug Discovery Market Share by Type (2018-2029)
- 6.3 North America Computational Drug Discovery Market Size by Application
- 6.3.1 North America Computational Drug Discovery Market Size by Application (2018-2023)
- 6.3.2 North America Computational Drug Discovery Market Size by Application (2024-2029)
- 6.3.3 North America Computational Drug Discovery Market Share by Application (2018-2029)
- 6.4 North America Computational Drug Discovery Market Size by Country
- 6.4.1 North America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
- 6.4.2 North America Computational Drug Discovery Market Size by Country (2018-2023)
- 6.4.3 North America Computational Drug Discovery Market Size by Country (2024-2029)
7 Europe
- 7.1 Europe Computational Drug Discovery Market Size (2018-2029)
- 7.2 Europe Computational Drug Discovery Market Size by Type
- 7.2.1 Europe Computational Drug Discovery Market Size by Type (2018-2023)
- 7.2.2 Europe Computational Drug Discovery Market Size by Type (2024-2029)
- 7.2.3 Europe Computational Drug Discovery Market Share by Type (2018-2029)
- 7.3 Europe Computational Drug Discovery Market Size by Application
- 7.3.1 Europe Computational Drug Discovery Market Size by Application (2018-2023)
- 7.3.2 Europe Computational Drug Discovery Market Size by Application (2024-2029)
- 7.3.3 Europe Computational Drug Discovery Market Share by Application (2018-2029)
- 7.4 Europe Computational Drug Discovery Market Size by Country
- 7.4.1 Europe Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
- 7.4.2 Europe Computational Drug Discovery Market Size by Country (2018-2023)
- 7.4.3 Europe Computational Drug Discovery Market Size by Country (2024-2029)
8 China
- 8.1 China Computational Drug Discovery Market Size (2018-2029)
- 8.2 China Computational Drug Discovery Market Size by Type
- 8.2.1 China Computational Drug Discovery Market Size by Type (2018-2023)
- 8.2.2 China Computational Drug Discovery Market Size by Type (2024-2029)
- 8.2.3 China Computational Drug Discovery Market Share by Type (2018-2029)
- 8.3 China Computational Drug Discovery Market Size by Application
- 8.3.1 China Computational Drug Discovery Market Size by Application (2018-2023)
- 8.3.2 China Computational Drug Discovery Market Size by Application (2024-2029)
- 8.3.3 China Computational Drug Discovery Market Share by Application (2018-2029)
9 Asia (excluding China)
- 9.1 Asia Computational Drug Discovery Market Size (2018-2029)
- 9.2 Asia Computational Drug Discovery Market Size by Type
- 9.2.1 Asia Computational Drug Discovery Market Size by Type (2018-2023)
- 9.2.2 Asia Computational Drug Discovery Market Size by Type (2024-2029)
- 9.2.3 Asia Computational Drug Discovery Market Share by Type (2018-2029)
- 9.3 Asia Computational Drug Discovery Market Size by Application
- 9.3.1 Asia Computational Drug Discovery Market Size by Application (2018-2023)
- 9.3.2 Asia Computational Drug Discovery Market Size by Application (2024-2029)
- 9.3.3 Asia Computational Drug Discovery Market Share by Application (2018-2029)
- 9.4 Asia Computational Drug Discovery Market Size by Region
- 9.4.1 Asia Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
- 9.4.2 Asia Computational Drug Discovery Market Size by Region (2018-2023)
- 9.4.3 Asia Computational Drug Discovery Market Size by Region (2024-2029)
10 Middle East, Africa, and Latin America
- 10.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size (2018-2029)
- 10.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Type (2018-2029)
- 10.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Application (2018-2029)
- 10.4 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
- 10.4.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2024-2029)
11 Key Players Profiles
- 11.1.1 AMRI Company Details
- 11.1.2 AMRI Business Overview
- 11.1.3 AMRI Computational Drug Discovery Introduction
- 11.1.4 AMRI Revenue in Computational Drug Discovery Business (2018-2023)
- 11.1.5 AMRI Recent Developments
- 11.2.1 Charles River Company Details
- 11.2.2 Charles River Business Overview
- 11.2.3 Charles River Computational Drug Discovery Introduction
- 11.2.4 Charles River Revenue in Computational Drug Discovery Business (2018-2023)
- 11.2.5 Charles River Recent Developments
- 11.3.1 Schrodinger Company Details
- 11.3.2 Schrodinger Business Overview
- 11.3.3 Schrodinger Computational Drug Discovery Introduction
- 11.3.4 Schrodinger Revenue in Computational Drug Discovery Business (2018-2023)
- 11.3.5 Schrodinger Recent Developments
- 11.4.1 Evotec Company Details
- 11.4.2 Evotec Business Overview
- 11.4.3 Evotec Computational Drug Discovery Introduction
- 11.4.4 Evotec Revenue in Computational Drug Discovery Business (2018-2023)
- 11.4.5 Evotec Recent Developments
- 11.5.1 Bayers Company Details
- 11.5.2 Bayers Business Overview
- 11.5.3 Bayers Computational Drug Discovery Introduction
- 11.5.4 Bayers Revenue in Computational Drug Discovery Business (2018-2023)
- 11.5.5 Bayers Recent Developments
- 11.6.1 GVK Biosciences Company Details
- 11.6.2 GVK Biosciences Business Overview
- 11.6.3 GVK Biosciences Computational Drug Discovery Introduction
- 11.6.4 GVK Biosciences Revenue in Computational Drug Discovery Business (2018-2023)
- 11.6.5 GVK Biosciences Recent Developments
- 11.7.1 AstraZeneca Company Details
- 11.7.2 AstraZeneca Business Overview
- 11.7.3 AstraZeneca Computational Drug Discovery Introduction
- 11.7.4 AstraZeneca Revenue in Computational Drug Discovery Business (2018-2023)
- 11.7.5 AstraZeneca Recent Developments
- 11.8.1 BioDuro Company Details
- 11.8.2 BioDuro Business Overview
- 11.8.3 BioDuro Computational Drug Discovery Introduction
- 11.8.4 BioDuro Revenue in Computational Drug Discovery Business (2018-2023)
- 11.8.5 BioDuro Recent Developments
- 11.9.1 BOC Sciences Company Details
- 11.9.2 BOC Sciences Business Overview
- 11.9.3 BOC Sciences Computational Drug Discovery Introduction
- 11.9.4 BOC Sciences Revenue in Computational Drug Discovery Business (2018-2023)
- 11.9.5 BOC Sciences Recent Developments
- 11.10 Aris Pharmaceuticals
- 11.10.1 Aris Pharmaceuticals Company Details
- 11.10.2 Aris Pharmaceuticals Business Overview
- 11.10.3 Aris Pharmaceuticals Computational Drug Discovery Introduction
- 11.10.4 Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2018-2023)
- 11.10.5 Aris Pharmaceuticals Recent Developments
- 11.11.1 ChemDiv Company Details
- 11.11.2 ChemDiv Business Overview
- 11.11.3 ChemDiv Computational Drug Discovery Introduction
- 11.11.4 ChemDiv Revenue in Computational Drug Discovery Business (2018-2023)
- 11.11.5 ChemDiv Recent Developments
- 11.12.1 RTI International Company Details
- 11.12.2 RTI International Business Overview
- 11.12.3 RTI International Computational Drug Discovery Introduction
- 11.12.4 RTI International Revenue in Computational Drug Discovery Business (2018-2023)
- 11.12.5 RTI International Recent Developments
- 11.13.1 XRQTC Company Details
- 11.13.2 XRQTC Business Overview
- 11.13.3 XRQTC Computational Drug Discovery Introduction
- 11.13.4 XRQTC Revenue in Computational Drug Discovery Business (2018-2023)
- 11.13.5 XRQTC Recent Developments
- 11.14.1 Pharmaron Company Details
- 11.14.2 Pharmaron Business Overview
- 11.14.3 Pharmaron Computational Drug Discovery Introduction
- 11.14.4 Pharmaron Revenue in Computational Drug Discovery Business (2018-2023)
- 11.14.5 Pharmaron Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach